Opportunities to improve surveillance of hepatocellular carcinoma in Australia.
作者信息
Howell Jess, Emery Jon D, Roberts Stuart, Thompson Alexander J, Ng Michael, George Jacob, Leggett Barbara A, Tse Edmund, Nguyen Bella, Combo Troy, Wigg Alan J
机构信息
Burnet Institute, Melbourne, VIC.
Monash University, Melbourne, VIC.
出版信息
Med J Aust. 2025 Jul 21;223(2):61-67. doi: 10.5694/mja2.52691. Epub 2025 Jun 8.
Abstract
摘要
相似文献
1
Opportunities to improve surveillance of hepatocellular carcinoma in Australia.改善澳大利亚肝细胞癌监测的机遇。
Med J Aust. 2025 Jul 21;223(2):61-67. doi: 10.5694/mja2.52691. Epub 2025 Jun 8.
2
A Health Economic Evaluation of Routine Hepatocellular Carcinoma Surveillance for People with Compensated Cirrhosis to Support Australian Clinical Guidelines.对代偿期肝硬化患者进行常规肝细胞癌监测的卫生经济学评估，以支持澳大利亚临床指南
MDM Policy Pract. 2025 Jun 26;10(1):23814683251344962. doi: 10.1177/23814683251344962. eCollection 2025 Jan-Jun.
3
Clinical outcomes of hepatocellular carcinoma surveillance in Melbourne, Australia.澳大利亚墨尔本的肝细胞癌监测的临床结果。
Intern Med J. 2024 Aug;54(8):1360-1368. doi: 10.1111/imj.16405. Epub 2024 Apr 26.
4
Magnetic resonance imaging for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.磁共振成像在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2022 May 6;5(5):CD014798. doi: 10.1002/14651858.CD014798.pub2.
5
Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.计算机断层扫描在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2021 Oct 6;10(10):CD013362. doi: 10.1002/14651858.CD013362.pub2.
6
Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.对比增强超声在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2022 Sep 2;9(9):CD013483. doi: 10.1002/14651858.CD013483.pub2.
7
Hepatocellular Carcinoma Surveillance and Survival in a Contemporary Asia-Pacific Cohort.当代亚太队列中的肝细胞癌监测与生存情况
JAMA Netw Open. 2025 Jul 1;8(7):e2520294. doi: 10.1001/jamanetworkopen.2025.20294.
8
Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.肝细胞癌肝硬化监测：系统评价与经济分析
Health Technol Assess. 2007 Sep;11(34):1-206. doi: 10.3310/hta11340.
9
Temporal change in aetiology and clinical characteristics of hepatocellular carcinoma in a large cohort of patients in New South Wales, Australia.澳大利亚新南威尔士州一大型队列患者肝癌病因和临床特征的时间变化。
Intern Med J. 2024 Apr;54(4):602-612. doi: 10.1111/imj.16252. Epub 2023 Oct 11.
10
Hepatocellular carcinoma surveillance among people living with hepatitis B in Senegal (SEN-B): insights from a prospective cohort study.塞内加尔乙型肝炎患者肝癌监测（SEN-B）：一项前瞻性队列研究的见解。
Lancet Gastroenterol Hepatol. 2024 Jun;9(6):539-549. doi: 10.1016/S2468-1253(24)00040-2. Epub 2024 Apr 6.
本文引用的文献
1
Cost-Effectiveness of Hepatocellular Carcinoma Surveillance Strategies in Patients With Compensated Liver Cirrhosis in the United Kingdom.英国代偿性肝硬化患者肝癌监测策略的成本效益分析。
Value Health. 2024 Dec;27(12):1698-1709. doi: 10.1016/j.jval.2024.07.015. Epub 2024 Aug 8.
2
Overcoming disparities in hepatocellular carcinoma outcomes in First Nations Australians: a strategic plan for action.消除澳大利亚原住民肝细胞癌治疗结果的差异：一项行动战略计划。
Med J Aust. 2024 Sep 2;221(5):230-235. doi: 10.5694/mja2.52395. Epub 2024 Aug 6.
3
The grade of obesity affects the noninvasive diagnosis of advanced fibrosis in individuals with MASLD.肥胖程度影响 MASLD 个体中晚期纤维化的非侵入性诊断。
Obesity (Silver Spring). 2024 Jun;32(6):1114-1124. doi: 10.1002/oby.24033. Epub 2024 May 3.
4
Early-stage hepatocellular carcinoma screening in patients with chronic hepatitis B in China: a cost-effectiveness analysis.中国慢性乙型肝炎患者早期肝细胞癌筛查的成本效益分析。
J Comp Eff Res. 2024 Apr;13(4):e230146. doi: 10.57264/cer-2023-0146. Epub 2024 Feb 28.
5
Development and clinical validation of a novel algorithmic score (GAAD) for detecting HCC in prospective cohort studies.前瞻性队列研究中用于检测 HCC 的新型算法评分（GAAD）的开发和临床验证。
Hepatol Commun. 2023 Nov 8;7(11). doi: 10.1097/HC9.0000000000000317. eCollection 2023 Nov 1.
6
Hepatocellular carcinoma surveillance in Australia: current and future perspectives.澳大利亚肝细胞癌监测：现状与未来展望。
Med J Aust. 2023 Nov 6;219(9):432-438. doi: 10.5694/mja2.52124. Epub 2023 Oct 6.
7
Surveillance, Diagnosis, and Treatment Outcome of Hepatocellular Carcinoma in Japan: 2023 Update.日本肝细胞癌的监测、诊断及治疗结果：2023年更新
Liver Cancer. 2023 Mar 9;12(2):95-102. doi: 10.1159/000530079. eCollection 2023 Jun.
8
AASLD Practice Guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma.美国肝病研究学会肝细胞癌预防、诊断和治疗实践指南。
Hepatology. 2023 Dec 1;78(6):1922-1965. doi: 10.1097/HEP.0000000000000466. Epub 2023 May 22.
9
Hepatocellular carcinoma surveillance based on the Australian Consensus Guidelines: a health economic modelling study.基于澳大利亚共识指南的肝细胞癌监测：一项健康经济建模研究。
BMC Health Serv Res. 2023 Apr 19;23(1):378. doi: 10.1186/s12913-023-09360-4.
10
Clinical Practice Guidelines for Hepatocellular Carcinoma: The Japan Society of Hepatology 2021 version (5th JSH-HCC Guidelines).肝细胞癌临床实践指南：日本肝脏学会2021版（第5版JSH-HCC指南）
Hepatol Res. 2023 May;53(5):383-390. doi: 10.1111/hepr.13892. Epub 2023 Mar 10.
Zotero 插件